Azilsartan Impurity 30 | CAS 2826360-62-5 - Request Quote
Azilsartan Impurity 30
| SZ CAT No: | SZ-A004055 |
| CAS No | 2826360-62-5 |
| Mol.F. | C10H10O7 |
| Mol.Wt. | 242.2 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Azilsartan Impurity 30 is chemically (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl (3-oxobut-1-en-2-yl) carbonate. Azilsartan Impurity 30 is supplied with detailed characterization data compliant with regulatory guideline. Azilsartan Impurity 30 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Azilsartan.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2826360-62-5
Purchase 2826360-62-5
Order 2826360-62-5
Enquire 2826360-62-5
price of 2826360-62-5
2826360-62-5 Supplier
2826360-62-5 Manufacturer
2826360-62-5 Exporter
buy high quality Azilsartan Impurity 30
Purchase Azilsartan Impurity 30
Azilsartan Impurity 30 suppliers
Azilsartan Impurity 30 manufacturers
Azilsartan Impurity 30 price
Order Azilsartan Impurity 30
Enquire Azilsartan Impurity 30
Azilsartan Impurity 30 cost
Azilsartan Impurity 30 Supplier
Azilsartan Impurity 30 Distributor
Azilsartan Impurity 30 for Method Validation
Azilsartan Reference Standard
Azilsartan Impurity 30 for ANDA Filing
Azilsartan Impurity 30 for Forced Degradation Studies
Azilsartan Impurity 30 Identification Standards
Azilsartan Impurity 30 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


